Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sjoerd D. Meenks"'
Autor:
Sjoerd D. Meenks, Nieko Punt, Jos L. M. L. le Noble, Norbert A. Foudraine, Kees Neef, Paddy K. C. Janssen
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-9 (2023)
Abstract Purpose Insufficient antimicrobial exposure has been associated with worse clinical outcomes. Reportedly, flucloxacillin target attainment in critically ill patients was heterogeneous considering the study population selection and reported t
Externí odkaz:
https://doaj.org/article/42bb37ae33444454aa0a844d66fa1e24
Autor:
Evine M. Appelman, Elisabeth A. Wammes van-der-Heijden, Sjoerd D. Meenks, Paddy K.C. Janssen, Jos L.M.L. le Noble
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 61:225-230
Autor:
Sjoerd D. Meenks, Jos L.M.L. le Noble, Norbert A. Foudraine, Frank de Vries, Kees Neef (C. Neef), Paddy K.C. Janssen
Publikováno v:
International Journal of Clinical Pharmacology and Therapeutics, 60(9), 373-383. Dustri-Verlag Dr. Karl Feistle
To develop a reliable 2-compartment population pharmacokinetic (PK) model for unbound ceftriaxone in a critically ill population and determine an optimal dosing regimen.This was a prospective, single-center, observational study of critically ill pati
Publikováno v:
International Journal of Clinical Pharmacology and Therapeutics, 58(4), 223-229. Dustri-Verlag Dr. Karl Feistle
Objective: Low-molecular-weight heparins are frequently used to prevent venous thromboembolism. Vasopressor therapy may be associated with inadequate anti-factor Xa activity, thereby increasing the risk of venous thromboembolism. We aimed to assess t
Autor:
Sjoerd D. Meenks, Frank de Vries, Jos L M L le Noble, Paddy K.C. Janssen, Norbert A. Foudraine
Publikováno v:
Current Clinical Pharmacology, 16(4), 341-349. Bentham Science Publishers
Background: Ceftriaxone is recommended for empiric antimicrobial therapy in patients with sepsis. Therapeutic Drug Monitoring (TDM) guided dose optimisation could elucidate pharmacokinetic variabilities, improving treatment efficacy. However, detaile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c5d3ed5fffc5e0f0c974ec74f1d971
https://cris.maastrichtuniversity.nl/en/publications/c9911ed8-ec26-4eff-a125-5d2e31b84a7c
https://cris.maastrichtuniversity.nl/en/publications/c9911ed8-ec26-4eff-a125-5d2e31b84a7c
Autor:
Kimberly N Shudofsky, Jos L M L le Noble, Joost J. van Raaij, Paddy K.C. Janssen, Noortje J D Mabelis, Sjoerd D. Meenks
Publikováno v:
Journal of Clinical Laboratory Analysis, 34(3):23100. Wiley
Journal of Clinical Laboratory Analysis
Journal of Clinical Laboratory Analysis
Background Pharmacokinetic studies of cefuroxime by ultra‐performance liquid chromatography tandem mass spectrometry (UPLC‐MS/MS) have been limited to measurements of total concentrations. Here, we developed a robust method for quantifying total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9720585a6198701c9124ad4aedd083ed
https://cris.maastrichtuniversity.nl/en/publications/1d9d524d-580f-41d7-9ec8-aaee159a9a05
https://cris.maastrichtuniversity.nl/en/publications/1d9d524d-580f-41d7-9ec8-aaee159a9a05
Autor:
Sjoerd D. Meenks, Norbert A. Foudraine, Paddy K.C. Janssen, Renée M F Ebisch, Jos L M L le Noble
Publikováno v:
Journal of Clinical Pharmacology, 60(1), 140-142. Wiley
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d6e14f4ad82d8272e9d6d62f308d16
https://cris.maastrichtuniversity.nl/en/publications/f6bd54d9-4a67-4c03-9d75-6f27ae5d6164
https://cris.maastrichtuniversity.nl/en/publications/f6bd54d9-4a67-4c03-9d75-6f27ae5d6164
Autor:
Nora J mabelis, Thomas Havenith, Sjoerd D. Meenks, Kimberly N Shudofsky, Joost J. van Raaij, Paddy K.C. Janssen, Sander Croes, Jos L M L le Noble
Publikováno v:
Journal of Applied Bioanalysis, Vol 4, Iss 5, Pp 166-174 (2018)
Journal of Applied Bioanalysis, 4(5), 166-174. Betasciencepress Publishers
Journal of Applied Bioanalysis, 4(5), 166-174. Betasciencepress Publishers
OBJECTIVES: To develop a reliable ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for therapeutic drug monitoring (TDM) of unbound ciprofloxacin concentrations in critically ill patients. METHODS: Total and unboun
Publikováno v:
Journal of Antimicrobial Chemotherapy, 74(1), 271-273. Oxford University Press
Publikováno v:
International Journal of Clinical Pharmacology and Therapeutics, 56(3), 148-150. Dustri-Verlag Dr. Karl Feistle